Dual Mechanism of Severe Bleeding Diathesis in a Patient with CLL: Acquired Von Willebrand Syndrome and Ibrutinib

Bürki, SusanneSusanneBürkiNovak, UrbanUrbanNovak2024-09-022024-09-022020-03-17https://boris-portal.unibe.ch/handle/20.500.12422/37213We here report an informative case of severe bleeding diathesis in a patient with Chronic Lymphocytic Leukaemia (CLL), due to Acquired Von Willebrand Syndrome (AVWS) and impaired platelets aggregation under the treatment with Ibrutinib. Keywords: CLL; Acquired von Willebrand syndrome; Ibrutinib; Bleedingen600 - Technology::610 - Medicine & healthDual Mechanism of Severe Bleeding Diathesis in a Patient with CLL: Acquired Von Willebrand Syndrome and Ibrutinib - Mediated Platelets Dysfunctionarticle10.7892/boris.146722